| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
31,094 | 31,094 | 36,034 | 113,970 | 181,076 |
|
Cost of Revenue
|
-9,256 | -9,256 | -14,408 | -67,882 | -96,481 |
|
Gross Profit
|
21,838 | 21,838 | 21,626 | 46,088 | 84,595 |
| Selling, General and Administrative Expenses
|
-29,688 | -29,688 | -39,449 | -68,563 | -75,281 |
| Provision Expense/Write-Back
|
53 | 53 | -69,616 | -- | -- |
| Other Income/Expense, Operating
|
0 | 0 | 31 | 0 | 383 |
|
Operating Income/Expenses
|
-29,635 | -29,635 | -109,034 | -68,563 | -74,898 |
|
Total Operating Profit/Loss
|
-7,797 | -7,797 | -87,408 | -22,475 | 9,697 |
| Total Net Finance Income/Expense
|
-16,216 | -16,216 | -15,890 | -270 | -4,561 |
| Net Investment Income
|
-19,369 | -19,369 | -1,799 | -1,427 | 0 |
| Irregular Income/Expenses
|
-220 | -220 | -59,535 | -20,519 | -2,129 |
|
Other Income/Expense, Non-Operating
|
439 | 439 | 67 | 437 | 399 |
|
Non-Operating Income/Expenses, Total
|
-35,366 | -35,366 | -77,157 | -21,779 | -6,291 |
|
Pretax Income
|
-43,163 | -43,163 | -164,565 | -44,254 | 3,406 |
|
Provision for Income Tax
|
0 | 0 | -548 | -2,193 | -5,642 |
|
Net Income from Continuing Operations
|
-43,163 | -43,163 | -165,113 | -46,447 | -2,236 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-43,163 | -43,163 | -165,113 | -46,447 | -2,236 |
|
Net Income after Non-Controlling/Minority Interests
|
-43,163 | -43,163 | -165,113 | -46,447 | -2,236 |
|
Net Income Available to Common Stockholders
|
-43,163 | -43,163 | -165,113 | -46,447 | -2,236 |
|
Diluted Net Income Available to Common Stockholders
|
-43,163 | -43,163 | -165,113 | -46,447 | -2,236 |
| Basic EPS
|
-0.10 | -0.10 | -0.37 | -0.13 | -0.01 |
| Diluted EPS
|
-0.10 | -0.10 | -0.37 | -0.13 | -0.01 |
|
Basic Weighted Average Shares Outstanding
|
444,294 | 444,294 | 440,855 | 370,245 | 370,245 |
|
Diluted Weighted Average Shares Outstanding
|
444,294 | 444,294 | 440,855 | 370,245 | 370,245 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-26,947 | -26,947 | -148,675 | -43,984 | 7,967 |
|
EBITDA
|
-26,309 | -26,309 | -146,823 | -41,649 | 9,693 |
|
Normalized EBITDA
|
-26,089 | -26,089 | -87,221 | -21,130 | 11,822 |
|
Normalized Income
|
-42,943 | -42,943 | -105,511 | -25,928 | -107 |
|
Total Unusual Items
|
220 | 220 | 59,602 | 20,519 | 2,129 |
12/31/2022 - 8/6/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade